BCTU is moving offices
We expect this to happen on 17th & 18th July. Please note we will have limited access to telephones and emails during these two days.
The move should not cause too much disruptions to the team, although it may affect our ability to get PD GEN packs out to research staff in a timely fashion. If your site needs any packs in the next month or two, please get the request to us now and we will send them out early as a precautionary action.
Our new address effective from 21st July 2014:
Neuroscience Trials Office
Birmingham Clinical Trials Unit
Public Health Building
School of Health & Population Sciences
University of Birmingham
BCTU Parkinson's PPI Group is now up and running
We have invited a number of people with Parkinson's and their carers to join our Patient and Public Involvement Group. The purpose of this group is to improve our research by ensuring we are asking the right questions and are communicating with trial participants & the broader community most effectively. Over the past few weeks, the group has already kindly given us a helping hand on the grant application and result dissemination.
The trials team would like to thank those who have joined the group and kindly dedicated their time to our research, helping to bring our research closer to patients and the public.
PD MED trial result paper (Early disease) is now published online
We are very pleased to announce that analysis on the PD MED Early disease data is now published online by the The Lancet. For further details, visit our Publication page. Please note the full article currently is available only on subscription to the journal.
The PD MED study looks at the clinical and cost effectiveness of different classes of PD medications. The analysis of this paper is based on 7 years of participant follow up by clinicians and participant self reported scores of mobility and quality of life of 1620 participants diagnosed with early PD who were recruited into the study back in 2000-2009.